Pay in 4 interest-free payments of $5.56 Learn more
Ships within 48 hours · Estimated delivery Oct 12 - Oct 17
A dual GLP-1/GIP receptor agonist that typically produces greater weight loss than semaglutide, particularly for patients at higher BMIs or with significant insulin resistance
Coverage that existed in 2024 may not exist in 2026
It works while youre taking it, but the underlying condition requires ongoing management
We also measured health utilization, including the number of hospitalizations and outpatient visits in the past year
This makes it an excellent choice for researchers and professionals who need reliable and high-quality compounds for testing and study
US$ 21.23
US$ 28.10
US$ 20.62
US$ 20.40
US$ 25.08
US$ 26.66
US$ 27.07
US$ 24.86
